Regarding BMI, our results showed that GLP-1 agonists had a progressive impact on BMI reduction over time, with statistically significant effects emerging at 6 months and persisting up to 24 months, at 3 months, the mean difference (MD) was 0.36 (95% CI: 1.22, 0.50) with 0.0% heterogeneity ( I 2 ) and a p -value of 0.4102
How long the appointments take A once-weekly injection you self-administer within an ongoing, provider-managed program
Therefore, more extensive randomized controlled trials (RCTs) are essential to elucidate these relationships and inform clinical practice
It is also used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease
If you have recent labs from your primary care doctor, bring themwe may not need to repeat all of them
According to the company, the clinician retains sole discretion to prescribe compounded GLP-1 medications